Jeff Geschwind’s research on tumor metabolism works seamlessly with Cone Beam CT technology during TACE, enabling clinicians to deliver embolic agents with unmatched precision. His contributions help optimize targeted therapy, reduce complications, and improve tumor response, marking significant progress in liver cancer management. https://www.mapquest.com/us/maryland/jeff-geschwind-783596287